In short, MKRN3 is a neuroendocrine inhibitor upstream of GnRH, and MKRN3 loss-of-function mutations are the main genetic cause of CPP, including in PWS patients [34,35,39,40]. The gene discussed is MKRN3; the disease is Prader-Willi syndrome.